177
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Neurological and Psychiatric Comorbidities in Chronic Obstructive Pulmonary Disease

, ORCID Icon &
Pages 553-562 | Published online: 03 Mar 2021

References

  • Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
  • Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368. doi:10.1136/bmj.m234.
  • Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi:10.1016/S0140-6736(18)32335-3
  • Yin H, Yin S, Lin Q, Xu Y, Xu H, Liu T. Prevalence of comorbidities in chronic obstructive pulmonary disease patients. Medicine. 2017;96(19):e6836. doi:10.1097/MD.0000000000006836
  • Matte DL, Pizzichini MMM, Hoepers ATC, et al. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–161. doi:10.1016/j.rmed.2016.06.006
  • Pelgrim CE, Peterson JD, Gosker HR, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both? Eur J Pharmacol. 2019;842:99–110. doi:10.1016/j.ejphar.2018.10.001
  • Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36(4):575–591. doi:10.1055/s-0035-1556063
  • Söderholm M, Inghammar M, Hedblad B, Egesten A, Engström G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159–168. doi:10.1007/s10654-015-0113-7
  • Rehman A, Hassali MAA, Muhammad SA, Harun SN, Shah S, Abbas S. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. Eur J Health Econ. 2020;21(2):181–194. doi:10.1007/s10198-019-01119-1
  • Houben-Wilke S, Triest FJJ, Franssen FME, Janssen DJA, Wouters EFM, Vanfleteren LEGW. Revealing methodological challenges in chronic obstructive pulmonary disease studies assessing comorbidities: a narrative review. COPD. 2019;6(2):166–177. doi:10.15326/jcopdf.6.2.2018.0145
  • Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. doi:10.1164/rccm.201209-1665OC
  • Triest FJJ, Franssen FME, Reynaert N, et al. Disease-specific comorbidity clusters in COPD and accelerated aging. J Clin Med. 2019;8(4):511. doi:10.3390/jcm8040511
  • Faner R, Agustí A. Network analysis: a way forward for understanding COPD multimorbidity. Eur Respir J. 2015;46(3):591–592. doi:10.1183/09031936.00054815
  • Incalzi RA, Canonica GW, Scichilone N, Rizzoli S, Simoni L, Blasi F. The COPD multi-dimensional phenotype: a new classification from the STORICO Italian observational study. PLoS One. 2019;14(9). doi:10.1371/journal.pone.0221889
  • Siafakas N, Corlateanu A, Fouka E. Phenotyping before starting treatment in COPD? COPD. 2017;14(3):367–374. doi:10.1080/15412555.2017.1303041
  • Vazquez Guillamet R, Ursu O, Iwamoto G, Moseley PL, Oprea T. Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records. Health Informatics J. 2018;24(4):394–409. doi:10.1177/1460458216675661
  • Postma DS, Anzueto AR, Jenkins C, et al. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics. Respir Med. 2013;107(12):1939–1947. doi:10.1016/j.rmed.2013.07.011
  • Yoon HY, Park SY, Lee CH, et al. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis. Int J COPD. 2019;14:1389–1397. doi:10.2147/COPD.S205517
  • Franssen FME, Alter P, Bar N, et al. Personalized medicine for patients with COPD: where are we? Int J COPD. 2019;14:1465–1484. doi:10.2147/COPD.S175706
  • Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, Impact, And management of depression and anxiety in chronic obstructive pulmonary disease. Int J COPD. 2014;9:1289–1306. doi:10.2147/COPD.S72073
  • Yohannes AM, Junkes-Cunha M, Smith J, Vestbo J. Management of dyspnea and anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18(12):1096.e1–1096.e17. doi:10.1016/j.jamda.2017.09.007
  • McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2013;22(129):365–375. doi:10.1183/09059180.00003213
  • Owens RL, Macrea MM, Teodorescu M. The overlaps of asthma or COPD with OSA: a focused review. Respirology. 2017;22(6):1073–1083. doi:10.1111/resp.13107
  • McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev. 2019;28(153):190064. doi:10.1183/16000617.0064-2019
  • Olaithe M, Bucks RS, Hillman DR, Eastwood PR. Cognitive deficits in obstructive sleep apnea: insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med Rev. 2018;38:39–49. doi:10.1016/j.smrv.2017.03.005
  • DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13(16):1–33.
  • Navickas R, Visockiene PR, Rukšeniene M, Kasiulevičius V, Jurevičiene E, Jurevičienė E. Prevalence and structure of multiple chronic conditions in Lithuanian population and the distribution of the associated healthcare resources. Eur J Intern Med. 2015;26(3):160–168. doi:10.1016/j.ejim.2015.02.015
  • Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-2
  • Woodfield R, Grant I, Sudlow CLM. Accuracy of electronic health record data for identifying stroke cases in large-scale epidemiological studies: a systematic review from the UK Biobank Stroke Outcomes Group. PLoS One. 2015;10(10). doi:10.1371/journal.pone.0140533
  • Busija L, Lim K, Szoeke C, Sanders KM, McCabe MP. Do replicable profiles of multimorbidity exist? Systematic review and synthesis. Eur J Epidemiol. 2019;34(11):1025–1053. doi:10.1007/s10654-019-00568-5
  • Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):7–16. doi:10.1016/j.ccm.2013.10.002
  • Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med. 2017;23(2):117–123. doi:10.1097/MCP.0000000000000353
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
  • Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, et al. COPD course and comorbidities: are there gender differences? Adv Exp Med Biol. 2019;1113:43–51. doi:10.1007/5584_2018_160
  • Health statistics portal of institute of hygiene; 2021. Available from: https://stat.hi.lt/user-report-view.aspx?group_id=29. Accessed February 16, 2021.
  • Divo MJ, Celli BR, Poblador-Plou B, et al. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the epichron cohort. PLoS One. 2018;13(2):e0193143. doi:10.1371/journal.pone.0193143
  • Lahousse L, Tiemeier H, Ikram MA, Brusselle GG. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015;109(11):1371–1380. doi:10.1016/j.rmed.2015.07.014
  • Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci. 2016;130(13):1039–1050. doi:10.1042/CS20160043
  • Li C-H, Chen W-C, Liao W-C, et al. The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide population-based retrospective cohort study. QJM. 2015;108(1):39–45. doi:10.1093/qjmed/hcu136
  • Wang Y, Li X, Wei B, Tung T-H, Tao P, Chien C-W. Association between chronic obstructive pulmonary disease and dementia: systematic review and meta-analysis of cohort studies. Dement Geriatr Cogn Dis Extra. 2019;9(2):250–259. doi:10.1159/000496475
  • Tondo G, De Marchi F, Terazzi E, et al. Chronic obstructive pulmonary disease may complicate Alzheimer’s disease: a comorbidity problem. Neurol Sci. 2018;39(9):1585–1589. doi:10.1007/s10072-018-3470-7
  • Sen A, Capelli V, Husain M. Cognition and dementia in older patients with epilepsy. Brain. 2018;141(6):1592–1608. doi:10.1093/brain/awy022
  • Emsley HCA, Parkes LM. Seizures in the context of occult cerebrovascular disease. Epilepsy Behav. 2020;104:106396. doi:10.1016/j.yebeh.2019.06.039
  • Keret O, Hoang TD, Xia F, Rosen HJ, Yaffe K. Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans. JAMA Neurol. 2020;77(6):E1–E6. doi:10.1001/jamaneurol.2020.0187
  • De Reuck J, Proot P, Van Maele G. Chronic obstructive pulmonary disease as a risk factor for stroke-related seizures. Eur J Neurol. 2007;14(9):989–992. doi:10.1111/j.1468-1331.2007.01829.x
  • Wang JZ, Vyas MV, Saposnik G, Burneo JG. Incidence and management of seizures after ischemic stroke. Neurology. 2017;89(12):1220–1228. doi:10.1212/WNL.0000000000004407
  • Ferguson CJ, Stanley M, Souchek J, Kunik ME. The utility of somatic symptoms as indicators of depression and anxiety in military veterans with chronic obstructive pulmonary disease. Depress Anxiety. 2006;23(1):42–49. doi:10.1002/da.20136
  • Ouellette DR, Lavoie KL. Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD. Int J COPD. 2017;2017:12–639. doi:10.2147/COPD.S123994
  • Mcnicholas WT. COPD-OSA overlap syndrome evolving evidence regarding epidemiology, clinical consequences, and management. Chest. 2017;152(6):1318–1326. doi:10.1016/j.chest.2017.04.160
  • Economou N-T, Ilias I, Velentza L, et al. Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea – overlap – syndrome, before and after continuous positive airways pressure therapy. PLoS One. 2018;13(6):e0197342. doi:10.1371/journal.pone.0197342
  • Vanfleteren LE, Beghe B, Andersson A, Hansson D, Fabbri LM, Grote L. Multimorbidity in COPD, does sleep matter? Eur J Intern Med. 2020;73:7–15. doi:10.1016/j.ejim.2019.12.032
  • Gupta MA, Simpson FC, Lyons DCA. The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: a systematic review and meta-analysis. Sleep Med Rev. 2016;28:55–68. doi:10.1016/j.smrv.2015.07.002